R M D'Ortenzio

  • Citations Per Year
Learn More
BACKGROUND AND PURPOSE Quantitative CBF usage as a biomarker for cognitive impairment and disease progression in MS is potentially a powerful tool for longitudinal patient monitoring. Dynamic(More)
  • 1